EPA Extends and Expands Contract with Expression Analysis.DURHAM, N.C. -- Expression Analysis, a full-service genetics testing and services company specializing in the Affymetrix GeneChip(R) Brand technology, announced today that the Environmental Protection Agency Environmental Protection Agency (EPA), independent agency of the U.S. government, with headquarters in Washington, D.C. It was established in 1970 to reduce and control air and water pollution, noise pollution, and radiation and to ensure the safe handling and (EPA EPA eicosapentaenoic acid. EPA abbr. eicosapentaenoic acid EPA, n.pr See acid, eicosapentaenoic. EPA, n. ) has extended and expanded its existing contract with the company. The current contract option period recently exercised, with a maximum value of more than $1.7 million annually, has been expanded by the EPA to include additional services and technologies developed by Expression Analysis. These additions increase the contracts maximum value up to more than $2.5 million for this year alone, taking the maximum value of the entire contract to $6 million dollars. In submitted performance reports, the EPA has stated that Expression Analysis has provided "processing service and data that is of excellent quality", and customer services that have been rated as "outstanding". "EA works very hard to maintain customer satisfaction", commented the EPA. In addition to adding the latest in Affymetrix GeneChip products, the contract now allows for access to statistical tools developed at Expression Analysis to include Reduction of Invariant Probes (REDI)(TM), Permutation One possible combination of items out of a larger set of items. For example, with the set of numbers 1, 2 and 3, there are six possible permutations: 12, 21, 13, 31, 23 and 32. (mathematics) permutation - 1. Analysis of Differential Expression (PADE)(TM) and other analysis and normalization methods. "The EPA and Expression Analysis have worked together for over 2 years," said Steve Casey, Expression Analysis' founder and COO. "We are pleased to be a part of their research efforts and look forward to supporting them well into the future with the industry leading Affymetrix brand technology and other cutting edge tools employed or developed here at Expression Analysis", Casey said. Expression Analysis, one of this year's Entrepreneur Magazine Hot 100 companies, has collaborated with industry and the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. to facilitate use of genomic data in clinical trials and is on track to processes more than 50 pharmacogenomic related clinical trials this year. The company was the first microarray services laboratory to achieve GLP See gateway location protocol. compliance and CLIA CLIA Clinical Laboratory Improvement Amendments of 1988 Congressional legislation that promulgated quality assurance practices in clinical labs, and required them to measure performance at each step of the testing process from the beginning to the end-point of a registration. With services such as globin globin /glo·bin/ (glo´bin) 1. the protein constituent of hemoglobin. 2. any of a group of proteins similar to the typical globin. glo·bin n. reduction protocols, Proficiency Testing for microarrays laboratories, SNP Imputation IMPUTATION. The judgment by which we declare that an agent is the cause of his free action, or of the result of it, whether good or ill. Wolff, Sec. 3. tools and high-density genotyping, the company has established itself as the leader in the microarray-based pharmacogenomic testing. About Expression Analysis, Inc. Expression Analysis, Inc. (http://www.expressionanalysis.com) is a full-service microarray genetics testing and analysis organization that provides high-quality genomic processing and data analysis services using Affymetrix GeneChip(R) technology. EA is one of the few U.S.-based authorized service providers for Affymetrix, Inc. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion